Upregulation of collagenase-1 and -3 in indomethacin-induced gastric ulcer in diabetic rats: Role of melatonin

Journal of Pineal Research

Volumn 51, Issue 1, 2011, Pages 61-74

  Pradeepkumar Singh, Laishram ^a   Vivek Sharma, Anamika ^a   Swarnakar, Snehasikta ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

collagenases; diabetes; gastric ulcer; matrix metalloproteinases; melatonin

Indexed keywords

COLLAGENASE 3; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN 70; INDOMETACIN; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MELATONIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STREPTOZOCIN; STROMELYSIN; SYNAPSIN I; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; DISEASE PREDISPOSITION; DOWN REGULATION; DRUG EFFECT; DRUG EXPOSURE; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOREACTIVITY; MALE; NONHUMAN; PREMEDICATION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STOMACH; STOMACH INJURY; STOMACH MUCOSA; STOMACH PROTECTION; STOMACH ULCER; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; COLLAGENASES; DIABETES MELLITUS, EXPERIMENTAL; DRUG INTERACTIONS; GELATINASES; HISTOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INDOMETHACIN; MALE; MATRIX METALLOPROTEINASE 13; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY; STOMACH ULCER; UP-REGULATION;

EID: 79960342631     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2010.00845.x     Document Type: Article

References (62)

1. Brownlee M,. Biochemistry and molecular cell biology of diabetic comp (Pubitemid 34000785)
2. Zimmet P, Alberti KG, Shaw J,. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787. (Pubitemid 34000780)
3. Harsch IA, Brzozowski T, Bazela K, et al., Impaired gastric ulcer healing in diabetic rats: role of heat shock protein, growth factors, prostaglandins and proinflammatory cytokines. Eur J Pharmacol 2003; 481: 249-260. (Pubitemid 37464977)
4. Korolkiewicz RP, Tashima K, Fujita A, et al., Exogenous insulin-like growth factor (IGF)-1 improves the impaired healing of gastric mucosal lesions in diabetic rats. Pharmacol Res 2000; 41: 221-229. (Pubitemid 30670338)
5. Glavin GB, Szabo S,. Experimental gastric mucosal injury: laboratory models reveal mechanisms of pathogenesis and new therapeutic strategies. FASEB J 1992; 6: 825-831.
6. Hernandez-Munoz R, Montiel-Ruiz C, Vazquez-Martinez O,. Gastric mucosal cell proliferation in ethanol-induced chronic mucosal injury is related to oxidative stress and lipid peroxidation in rats. Lab Invest 2000; 80: 1161-1169. (Pubitemid 30637056)
7. Slomiany BL, Piotrowski J, Slomiany A,. Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine. Scand J Gastroenterol 1997; 32: 638-642. (Pubitemid 27334471)
8. Yoshikawa T, Naito Y, Kishi A, et al., Role of active oxygen, lipid peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by indomethacin in rats. Gut 1993; 34: 732-737. (Pubitemid 23185094)
9. Parks WC, Mecham RP,. Matrix Metalloproteinases. Academic Press, New York, 1998.
10. Lempinen M, Inkinen K, Wolff H, et al., Matrix metalloproteinases 2 and 9 in indomethacin-induced rat gastric ulcer. Eur Surg Res 2000; 32: 169-176. (Pubitemid 30456779)
11. Shahin M, Konturek JW, Pohle T, et al., Remodeling of extracellular matrix in gastric ulceration. Microsc Res Tech 2001; 53: 396-408. (Pubitemid 32525714)
12. Swarnakar S, Ganguly K, Kundu P, et al., Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem 2005; 280: 9409-9415. (Pubitemid 40409634)
13. Ganguly K, Maity P, Reiter RJ, et al., Effect of melatonin on secreted and induced matrix metalloproteinase-9 and -2 activity during prevention of indomethacin-induced gastric ulcer. J Pineal Res 2005; 39: 307-315. (Pubitemid 41337813)
14. Pradeepkumar Singh L, Kundu P, Ganguly K, et al., Novel role of famotidine in downregulation of matrix metalloproteinase-9 during protection of ethanol-induced acute gastric ulcer. Free Radic Biol Med 2007; 43: 289-299. (Pubitemid 46992709)
15. Swarnakar S, Mishra A, Ganguly K, et al., Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice. J Pineal Res 2007; 43: 56-64. (Pubitemid 47035222)
16. Otani Y, Sakurai Y, Kameyama K, et al., Matrix metalloproteinase gene expression in chronic gastric ulcer: a potential role of eosinophils in perforation. J Clin Gastroenterol 1997; 25: S101-S104. (Pubitemid 28117014)
17. Yan C, Boyd DD,. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 2007; 211: 19-26. (Pubitemid 46363892)
18. Westermarck J, Kahari VM,. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 1999; 13: 781-792. (Pubitemid 29220691)
19. Zhang SX, Wang JJ, Lu K, et al., Therapeutic potential of angiostatin in diabetic nephropathy. J Am Soc Nephrol 2006; 17: 475-486.
20. Jin M, Kashiwagi K, Iizuka Y, et al., Matrix metalloproteinases in human diabetic and nondiabetic vitreous. Retina 2001; 21: 28-33. (Pubitemid 32151759)
21. Lobmann R, Ambrosch A, Schultz G, et al., Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-1016. (Pubitemid 34762196)
22. Maxwell PR, Timms PM, Chandran S, et al., Peripheral blood level alterations of TIMP-1, MMP-2 and MMP-9 in patients with type 1 diabetes. Diabet Med 2001; 18: 777-780. (Pubitemid 32953782)
23. Muller M, Trocme C, Lardy B, et al., Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing. Diabet Med 2008; 25: 419-426. (Pubitemid 351490124)
24. Uemura S, Matsushita H, Li W, et al., Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ Res 2001; 88: 1291-1298. (Pubitemid 32587846)
25. Gharagozlian S, Svennevig K, Bangstad HJ, et al., Matrix metalloproteinases in subjects with type 1 diabetes. BMC Clin Pathol 2009; 9: 7.
26. Shiau MY, Tsai ST, Tsai KJ, et al., Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus. Mt Sinai J Med 2006; 73: 1024-1028.
27. Derosa G, Avanzini MA, Geroldi D, et al., Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract 2005; 70: 119-125. (Pubitemid 41368059)
28. Reiter RJ,. Pineal control of a seasonal reproductive rhythm in male golden hamsters exposed to natural daylight and temperature. Endocrinology 1973; 92: 423-430.
29. Redman J, Armstrong S, Ng KT,. Free-running activity rhythms in the rat: entrainment by melatonin. Science 1983; 219: 1089-1091. (Pubitemid 13138454)
30. Dawson D, Encel N,. Melatonin and sleep in humans. J Pineal Res 1993; 15: 1-12. (Pubitemid 23297608)
31. Paradies G, Petrosillo G, Paradies V, et al., Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 2010; 48: 297-310.
32. Gitto E, Pellegrino S, Gitto P, et al., Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 2009; 46: 128-139.
33. Montilla PL, Vargas JF, Tunez IF, et al., Oxidative stress in diabetic rats induced by streptozotocin: protective effects of melatonin. J Pineal Res 1998; 25: 94-100. (Pubitemid 28392105)
34. Ihnat MA, Thorpe JE, Kamat CD, et al., Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling. Diabetologia 2007; 50: 1523-1531. (Pubitemid 46879013)
35. Gardner H, Broberg A, Pozzi A, et al., Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J Cell Sci 1999; 112 (Pt 3): 263-272. (Pubitemid 29080649)
36. Kundu P, Mukhopadhyay AK, Patra R, et al., Cag pathogenicity island-independent up-regulation of matrix metalloproteinases-9 and -2 secretion and expression in mice by Helicobacter pylori infection. J Biol Chem 2006; 281: 34651-34662. (Pubitemid 46036671)
37. Archanco M, Muruzabal FJ, Llopiz D, et al., Leptin expression in the rat ovary depends on estrous cycle. J Histochem Cytochem 2003; 51: 1269-1277. (Pubitemid 37187578)
38. Kasperczyk H, La Ferla-Bruhl K, Westhoff MA, et al., Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy. Oncogene 2005; 24: 6945-6956. (Pubitemid 41509417)
39. Paul S, Bhattacharya P, Das Mahapatra P, et al., Melatonin protects against endometriosis via regulation of matrix metalloproteinase-3 and an apoptotic pathway. J Pineal Res 2010; 49: 156-168.
40. Bradford MM,. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
41. Gilliver SC, Ruckshanthi JP, Atkinson SJ, et al., Androgens influence expression of matrix proteins and proteolytic factors during cutaneous wound healing. Lab Invest 2007; 87: 871-881. (Pubitemid 47267813)
42. Nomura H, Fujimoto N, Seiki M, et al., Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int J Cancer 1996; 69: 9-16. (Pubitemid 26083264)
43. Chahbouni M, Escames G, Venegas C, et al., Melatonin treatment normalizes plasma pro-inflammatory cytokines and nitrosative/oxidative stress in patients suffering from Duchenne muscular dystrophy. J Pineal Res 2010; 48: 282-289.
44. Ganguly K, Swarnakar S,. Induction of matrix metalloproteinase-9 and -3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin. J Pineal Res 2009; 47: 43-55.
45. Webb KE, Henney AM, Anglin S, et al., Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. Arterioscler Thromb Vasc Biol 1997; 17: 1837-1844. (Pubitemid 27424009)
46. Baynes JW, Thorpe SR,. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9. (Pubitemid 29019345)
47. Fucci L, Oliver CN, Coon MJ, et al., Inactivation of key metabolic enzymes by mixed-function oxidation reactions: possible implication in protein turnover and ageing. Proc Natl Acad Sci U S A 1983; 80: 1521-1525. (Pubitemid 13052442)
48. Ganguly K, Kundu P, Banerjee A, et al., Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. Free Radic Biol Med 2006; 41: 911-925. (Pubitemid 44262480)
49. Hardeland R, Tan DX, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
50. Knauper V, Will H, Lopez-Otin C, et al., Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996; 271: 17124-17131. (Pubitemid 26244262)
51. Asea A, Kraeft SK, Kurt-Jones EA, et al., HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat Med 2000; 6: 435-442. (Pubitemid 30208161)
52. Konturek PC, Burnat G, Brzozowski T, et al., Tryptophan free diet delays healing of chronic gastric ulcers in rat. J Physiol Pharmacol 2008; 59 (Suppl 2): 53-65.
53. Pandi-Perumal SR, Trakht I, Srinivasan V, et al., Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008; 85: 335-353.
54. Guerrero JM, Reiter RJ,. Melatonin-immune system relationships. Curr Top Med Chem 2002; 2: 167-179.
55. Nelson KK, Melendez JA,. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med 2004; 37: 768-784. (Pubitemid 39078549)
56. Szczepanik M,. Melatonin and its influence on immune system. J Physiol Pharmacol 2007; 58 (Suppl 6): 115-124.
57. Carrillo-Vico A, Guerrero JM, Lardone PJ, et al., A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200. (Pubitemid 41558451)
58. Kojima K, Shimada T, Mitobe Y, et al., Effect of PPARgamma ligands on the viability of gastric epithelial cells. Aliment Pharmacol Ther 2002; 16: 67-73. (Pubitemid 41771464)
59. Choi JH, Banks AS, Estall JL, et al., Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 2010; 466: 451-456.
60. Diradourian C, Girard J, Pegorier JP,. Phosphorylation of PPARs: from molecular characterization to physiological relevance. Biochimie 2005; 87: 33-38. (Pubitemid 40298763)
61. Shaul YD, Seger R,. The MEK/ERK cascade: from signaling specificity to diverse functions. Biochim Biophys Acta 2007; 1773: 1213-1226. (Pubitemid 47125968)
62. Ramanan S, Kooshki M, Zhao W, et al., PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways. Free Radic Biol Med 2008; 45: 1695-1704.